• OPEN AN ACCOUNT
Indian Indices
Nifty
25,476.10 -46.40
(-0.18%)
Sensex
83,190.28 -345.80
( -0.41%)
Bank Nifty
57,213.55 -42.75
( -0.07%)
Nifty IT
38,680.85 -302.40
( -0.78%)
Global Indices
Nasdaq
44,477.29 215.52
(0.49%)
Dow Jones
6,283.97 37.45
(0.60%)
Hang Seng
39,601.95 -219.33
(-0.55%)
Nikkei 225
8,867.02 12.84
(0.15%)
Forex
USD-INR
85.73 -0.06
(-0.07%)
EUR-INR
100.55 -0.15
(-0.15%)
GBP-INR
116.58 -0.23
(-0.19%)
JPY-INR
0.59 0.00
(-0.73%)

EQUITY - MARKET SCREENER

Vanta Bioscience Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
540729
INE695X01011
31.3573796
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
17.54
EPS(TTM)
Face Value()
Div & Yield %
0.02
10
0
 

anupam finserv ltd
Mercantile Ventures reports consolidated net profit of Rs 9.09 crore in the March 2025 quarter
May 29,2025
Net profit of Mercantile Ventures reported to Rs 9.09 crore in the quarter ended March 2025 as against net loss of Rs 1.34 crore during the previous quarter ended March 2024. Sales rose 25.15% to Rs 19.26 crore in the quarter ended March 2025 as against Rs 15.39 crore during the previous quarter ended March 2024.

For the full year,net profit reported to Rs 17.32 crore in the year ended March 2025 as against net loss of Rs 4.26 crore during the previous year ended March 2024. Sales rose 19.54% to Rs 72.19 crore in the year ended March 2025 as against Rs 60.39 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales19.2615.39 25 72.1960.39 20
OPM %0.21-17.93 -1.810.13 -
PBDT1.98-0.72 LP 13.984.45 214
PBT1.73-0.93 LP 13.043.46 277
NP9.09-1.34 LP 17.32-4.26 LP